NDC 63323-417

Cisatracurium

Cisatracurium Besylate

Cisatracurium is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Cisatracurium Besylate.

Product ID63323-417_0d662c1d-2eef-4e5f-8610-fe606716c810
NDC63323-417
Product TypeHuman Prescription Drug
Proprietary NameCisatracurium
Generic NameCisatracurium Besylate
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2015-02-26
Marketing CategoryANDA / ANDA
Application NumberANDA203183
Labeler NameFresenius Kabi USA, LLC
Substance NameCISATRACURIUM BESYLATE
Active Ingredient Strength2 mg/mL
Pharm ClassesNeuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 63323-417-10

10 VIAL in 1 CARTON (63323-417-10) > 10 mL in 1 VIAL (63323-417-01)
Marketing Start Date2015-02-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63323-417-10 [63323041710]

Cisatracurium INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA203183
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2015-02-26

Drug Details

Active Ingredients

IngredientStrength
CISATRACURIUM BESYLATE2 mg/mL

OpenFDA Data

SPL SET ID:f78a07e2-0d3b-4460-b29e-8c10c90afbda
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 199212
  • 1730194
  • 199211
  • Pharmacological Class

    • Neuromuscular Nondepolarizing Blockade [PE]
    • Nondepolarizing Neuromuscular Blocker [EPC]

    NDC Crossover Matching brand name "Cisatracurium" or generic name "Cisatracurium Besylate"

    NDCBrand NameGeneric Name
    63323-418CisatracuriumCisatracurium
    63323-416CisatracuriumCisatracurium
    63323-417CisatracuriumCisatracurium
    0409-1098Cisatracurium BesylateCISATRACURIUM BESYLATE
    0409-1103Cisatracurium BesylateCISATRACURIUM BESYLATE
    0074-4378NimbexCisatracurium besylate
    0074-4380NimbexCisatracurium besylate
    0074-4382NimbexCisatracurium besylate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.